MMSI MERIT MEDICAL SYSTEMS INC
FY2025 10-K
MERIT MEDICAL SYSTEMS INC (MMSI) filed its fiscal year 2025 10-K annual report with the SEC on Feb 24, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Core business model: design, manufacture, and sell medical devices globally with emphasis on regulatory compliance and product lifecycle management
- • Regulatory challenges heightened by EU MDR certification delays, increased costs, and discontinuation of certain products in the E.U. this fiscal year
Management Discussion & Analysis
- • Revenue $1.516B in 2025, up 11.8% YoY ($159.4M increase from $1.357B in 2024), driven by U.S. and EMEA demand
- • Gross margin 48.7% in 2025 vs 47.4% in 2024; net income $128.5M (8.5% margin) vs $120.4M (8.9% margin)
Risk Factors
- • Supply chain reliance on limited sterilization service providers risks production delays if any ceases operation or compliance, potentially halting sales
- • Geopolitical tensions in Ukraine, Middle East, Venezuela increasing supply interruptions, elevating cost pressures on petroleum-based materials critical to manufacturing
Financial SummaryXBRL
Revenue
$1.5B
Net Income
$128M
Gross Margin
48.7%
Operating Margin
12.2%
Net Margin
8.5%
ROE
8.1%
Total Assets
$2.7B
EPS (Diluted)
$2.13
Operating Cash Flow
$297M
Source: XBRL data from MERIT MEDICAL SYSTEMS INC FY2025 10-K filing on SEC EDGAR. All figures in USD.
Get deeper insights on MERIT MEDICAL SYSTEMS INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.